BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25549144)

  • 1. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors.
    Zhu S; Schuerch C; Hunt J
    Arch Pathol Lab Med; 2015 Jan; 139(1):55-66. PubMed ID: 25549144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in mucin immunohistochemistry in salivary gland tumors and head and neck squamous cell carcinoma.
    Mahomed F
    Oral Oncol; 2011 Sep; 47(9):797-803. PubMed ID: 21723776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spin lock and magnetization transfer imaging of head and neck tumors.
    Markkola AT; Aronen HJ; Paavonen T; Hopsu E; Sipilä LM; Tanttu JI; Sepponen RE
    Radiology; 1996 Aug; 200(2):369-75. PubMed ID: 8685328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell adenocarcinoma of minor salivary and seromucous glands of the head and neck region.
    Fonseca I; Soares J
    Semin Diagn Pathol; 1996 May; 13(2):128-37. PubMed ID: 8734419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of immunohistochemistry in thyroid pathology.
    Liu H; Lin F
    Arch Pathol Lab Med; 2015 Jan; 139(1):67-82. PubMed ID: 25549145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross cystic disease fluid protein-15 in salivary gland tumors.
    Swanson PE; Pettinato G; Lillemoe TJ; Wick MR
    Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphous low-grade adenocarcinoma of the head and neck.
    Verma V; Mendenhall WM; Werning JW
    Am J Clin Oncol; 2014 Dec; 37(6):624-6. PubMed ID: 23428952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
    Mori Y; Tsukinoki K; Yasuda M; Miyazawa M; Kaneko A; Watanabe Y
    Oral Oncol; 2007 Jul; 43(6):563-9. PubMed ID: 17071132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on Immunohistochemical and Molecular Markers in Selected Head and Neck Diagnostic Problems.
    Yi CH; Jim Zhai Q; Wang BY
    Arch Pathol Lab Med; 2017 Sep; 141(9):1214-1235. PubMed ID: 28854343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the application of newly described immunohistochemical markers in soft tissue pathology.
    Lin G; Doyle LA
    Arch Pathol Lab Med; 2015 Jan; 139(1):106-21. PubMed ID: 25549147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual presentation of a salivary pleomorphic adenoma: a case report and review of the literature.
    Murphy RJ; Hendrix JD
    Cutis; 1999 Mar; 63(3):167-8. PubMed ID: 10190069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis of neck masses].
    Pérusse R
    J Can Dent Assoc; 1989 Oct; 55(10):825-9 concl. PubMed ID: 2679995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma.
    Mino M; Pilch BZ; Faquin WC
    Mod Pathol; 2003 Dec; 16(12):1224-31. PubMed ID: 14681323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mixed tumor (pleomorphic adenoma) of head and neck. Typical and atypical patterns].
    García Berrocal JR; Ramírez Camacho R; Trinidad A; Salas C
    An Otorrinolaringol Ibero Am; 2000; 27(4):333-40. PubMed ID: 11105334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis of common neck masses.
    Mesrobian AZ
    J Oral Med; 1973; 28(4):113-6. PubMed ID: 4519486
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis of head and neck neoplasms].
    Kato T; Takahashi H; Nakamuzo M; Uchida M
    Gan No Rinsho; 1989 Jan; Spec No():101-7. PubMed ID: 2915468
    [No Abstract]   [Full Text] [Related]  

  • 17. Manganese-enhanced MRI of salivary glands and head and neck tumors in living subjects.
    Seshadri M; Hoy A
    Magn Reson Med; 2010 Sep; 64(3):902-6. PubMed ID: 20806380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of deltaNp63 in salivary gland tumours].
    He ZX; Li YN; Liu LK; He HW; Wang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):126-8. PubMed ID: 16468660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nestin is a wide-spectrum abluminal cell marker of salivary gland tumors.
    Yanai H; Sato Y; Nagatsuka H; Yoshino T
    Pathol Int; 2013 Oct; 63(10):496-501. PubMed ID: 24147430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer.
    Leivo I
    Acta Oncol; 2006; 45(6):662-8. PubMed ID: 16938808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.